The acquisition of animal reference laboratory, Biovet, by Antech Diagnostics stands to provide Canadian veterinarians expanded access to diagnostics and laboratory services.
Based in Saint-Hyacinthe, Qué., Biovet operates a United States Department of Agriculture- (USDA-) and Canadian Food Inspection Agency- (CFIA-) certified laboratory, which serves veterinarians across Canada.
Under the terms of the agreement, the company will continue to provide clients with reference laboratory services. Additionally, it will offer expanded access to innovative diagnostics, including Antech’s new predictive diagnostic tool, RenalTech, which can indicate the onset of chronic kidney disease in cats two years before onset.
Biovet president and CEO, René Lallier, DVM, MBA, will continue to lead the company’s operations as general manager, overseeing its team of scientists and laboratory service professionals.
“For nearly three decades, Biovet has led Canada in high-quality laboratory services and diagnostic innovation,” Dr. Lallier says. “Joining with Antech is a natural blend of two like-minded organizations with a shared commitment to delivering innovation and quality to veterinarians, allowing them to deliver excellent, compassionate care to pets.”
The acquisition also adds extensive R&D assets to Antech’s offerings and supports the company’s goal of driving diagnostic advancements in animal health.
“We’re very pleased to welcome Biovet’s employees and customers to the Antech family,” says Antech’s chief operating officer (COO), Mary Kurian. “Biovet’s expertise in food and companion animal diagnostics both complements and enhances Antech’s strengths, accelerating our ability to expand services to veterinarians across North America. Biovet’s rich R&D pipeline will enhance our own, which translates to innovative new products and services that help veterinarians keep pets healthy.”